39 related articles for article (PubMed ID: 32700773)
1. Local injection of micro-dose guselkumab for acrodermatitis continua of Hallopeau after failure of systemic ixekizumab treatment.
Wang Y; Zhou C; Hou Y; Diao Z; Chen D; Yin Z
Int J Dermatol; 2024 Apr; 63(4):547-548. PubMed ID: 38228398
[No Abstract] [Full Text] [Related]
2. A retrospective analysis of 65 patients with acrodermatitis continua of Hallopeau.
Chularojanamontri L; Silpa-Archa N; Pattamadilok B; Julanon N; Chuamanochan M; Pongcharoen P; Lertphanichkul C; Asawanonda P
Exp Dermatol; 2024 Mar; 33(3):e15055. PubMed ID: 38519437
[TBL] [Abstract][Full Text] [Related]
3. Paediatric acrodermatitis continua of Hallopeau: perspectives of a patient and their mother.
O'Malley S; Duff E; Collins S
Clin Exp Dermatol; 2023 Dec; 49(1):92-93. PubMed ID: 37758513
[No Abstract] [Full Text] [Related]
4. Ixekizumab for the Treatment of Acrodermatitis Continua of Hallopeau and Inverse Psoriasis.
Xia RY; Liu J; Chen DD; Diao ZY; Gao YM; Yin ZQ
Indian J Dermatol; 2023; 68(2):234. PubMed ID: 37275799
[No Abstract] [Full Text] [Related]
5. Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report.
Cirone KD; Lovegrove FE
SAGE Open Med Case Rep; 2023; 11():2050313X231160937. PubMed ID: 36968989
[TBL] [Abstract][Full Text] [Related]
6. Visual Dermatology: Acrodermatitis Continua of Hallopeau.
Mir-Bonafé M; Mir-Bonafé JF
J Cutan Med Surg; 2020; 24(6):634. PubMed ID: 32731758
[No Abstract] [Full Text] [Related]
7. Acrodermatitis continua of Hallopeau: historical perspectives and modern management.
Bhate C; Schwartz RA
Ital J Dermatol Venerol; 2022 Apr; 157(2):132-136. PubMed ID: 35391533
[TBL] [Abstract][Full Text] [Related]
8. Etanercept for pediatric acrodermatitis continua of Hallopeau: A case report and literature review.
Ruggiero A; Patruno C; Napolitano M; Megna M; Gisonni P; Cirillo T; Fabbrocini G
Dermatol Ther; 2020 Nov; 33(6):e14046. PubMed ID: 32700773
[No Abstract] [Full Text] [Related]
9. Brodalumab in the treatment of recalcitrant acrodermatitis continua of Hallopeau.
Bardazzi F; Di Altobrando A; Lacava R
Dermatol Ther; 2020 Nov; 33(6):e14301. PubMed ID: 32920959
[No Abstract] [Full Text] [Related]
10. Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report.
Battista T; Guerrasio G; De Fata Salvatores G; Peduto T; Fabbrocini G; Di Guida A
Dermatol Ther; 2022 May; 35(5):e15383. PubMed ID: 35174591
[No Abstract] [Full Text] [Related]
11. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
[TBL] [Abstract][Full Text] [Related]
12. Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau.
Wang Y; Zhang L; Zheng J; Li X; Chen L
JAMA Dermatol; 2024 Apr; 160(4):476-477. PubMed ID: 38416455
[TBL] [Abstract][Full Text] [Related]
13. A case of acrodermatitis continua of Hallopeau evolving into generalized pustular psoriasis successfully treated with guselkumab.
Yamamoto H; Kamiya K; Okada H; Maekawa T; Komine M; Ohtsuki M
Int J Dermatol; 2023 Feb; 62(2):269-270. PubMed ID: 35187654
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
